Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Sobi and Selecta Announce Strategic Licensing Agreement for SEL-212, a Phase 3-ready Novel Treatment for Chronic Refractory Gout
Friday, June 12, 2020Swedish Orphan Biovitrum AB and Selecta Biosciences Inc Nasdaq SELB announced that the companies have entered into a strategic licensing agreement for the product candidate SEL SEL is a combination of Selectas tolerogenic ImmTOR immune tolerance pla...
Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda
Friday, June 12, 2020Egle Therapeutics SAS an emerging biotechnology company focused on developing firstinclass immunotherapies targeting immune suppressor regulatory Tcells for oncology and autoimmune diseases announced today a corporate strategic research alliance with...
DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline
Thursday, June 11, 2020DelMar Pharmaceuticals Inc and Adgero Biopharmaceuticals Holdings Inc Adgero today announced the companies have entered into a definitive merger agreement pursuant to which DelMar a biopharmaceutical company focused on the development of new solid tu...
BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1
Thursday, June 11, 2020BryoLogyx Incannounced it has entered into two agreements with Neurotrope Inc Nasdaq NTRP to acquire Neurotropes preclinical data package and drug product for use of bryostatin in an immunooncology application and to supply Neurotrope with synthetic...
Evox Therapeutics Announces a Multi-target RNAi and Antisense Research Collaboration and License Agreement With Lilly
Wednesday, June 10, 2020Evox Therapeutics Ltd a leading exosome therapeutics company is pleased to announce a research collaboration and license agreement with Eli Lilly and Company to leverage Evoxs proprietary DeliverEX platform to develop and deliver RNA interference RNA...
Lyvgen Announces Clinical Trial Collaboration With MSD
Wednesday, June 10, 2020Lyvgen a biopharmaceutical company focused on developing innovative immunooncology therapeutics announces that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck Co Inc Kenilworth New Jersey USA known as MSD outs...
Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer
Tuesday, June 09, 2020Alphamab Oncology a clinical stage biopharmaceutical company focusing on innovative biologics medicine for oncology and Sanofi a global biopharmaceutical leader announced today that Jiangsu Alphamab Biopharmaceuticals Co Ltd Jiangsu Alphamab a wholl...
A2A Pharmaceuticals Collaborates With LAXAI Life Sciences to Co-develop SARS-CoV-2 Main Proteases Inhibitors for the Treatment of COVID-19
Tuesday, June 09, 2020AA Pharmaceuticals a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents announces today an agreement to codevelop SARSCoV Main Proteases inhibitors for the treatment of COVID with Laxai Lif...
HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration
Monday, June 08, 2020HitGen announced that it has entered into a drug discovery research collaboration with Evotec SE to identify small molecule leads against targets of interest to Evotec SE in the field of antiinfectives HitGen will apply its platform technology based...
Ryvu Therapeutics Signs a Grant Agreement for the Development of Targeted Immuno-oncology Therapy
Saturday, June 06, 2020Ryvu Therapeutics a clinicalstage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology has signed a grant agreement with the National Centre for Research and Development for the development of...
